Note 12 —Loss Per Share
Loss per share is included below as of March 31 (in thousands except for share data):
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
|
2012 |
|
2011 |
|
Basic loss per share: |
|
|
|
|
|
Weighted-average common shares outstanding |
|
14,043,545 |
|
13,973,870 |
|
Weighted-average common shares less stock based awards |
|
13,855,339 |
|
13,769,856 |
|
Weighted-average common shares stock based awards |
|
340,804 |
|
443,845 |
|
Net loss |
|
$ |
(2,968 |
) |
$ |
(3,120 |
) |
Dividends and accretion of discount on preferred shares |
|
1,223 |
|
1,159 |
|
Net loss available to common stockholders |
|
(4,191 |
) |
(4,279 |
) |
Undistributed Loss |
|
(4,191 |
) |
(4,279 |
) |
Basic loss per share common undistributed loss |
|
(0.30 |
) |
(0.30 |
) |
Basic loss per share of common stock |
|
$ |
(0.30 |
) |
$ |
(0.30 |
) |
Diluted loss per share: |
|
|
|
|
|
Weighted-average common shares outstanding |
|
14,043,545 |
|
13,973,870 |
|
Dilutive effect of nonvested restricted awards |
|
152,598 |
|
239,831 |
|
Diluted average common shares outstanding |
|
14,196,143 |
|
14,213,701 |
|
Net loss available to common stockholders |
|
$ |
(4,191 |
) |
$ |
(4,279 |
) |
Diluted loss per share |
|
$ |
(0.30 |
) |
$ |
(0.30 |
) |
|
|
|
|
|
|
Number of antidilutive options excluded from the diluted earnings per share calculation |
|
1,313,839 |
|
1,416,171 |
|
The above loss per share calculation did not include 815,339 common stock warrants that were outstanding as of March 31, 2012 and March 31, 2011.
|